TSE:OGI Organigram (OGI) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free OGI Stock Alerts C$2.60 -0.01 (-0.38%) (As of 04/22/2024 ET) Add Compare Share Share Today's RangeC$2.54▼C$2.6850-Day RangeC$2.50▼C$3.6752-Week RangeC$1.35▼C$3.95Volume244,863 shsAverage Volume401,455 shsMarket CapitalizationC$244.66 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.85 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines Get Organigram alerts: Email Address Organigram MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside48.1% UpsideC$3.85 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.24Based on 3 Articles This WeekInsider TradingSelling SharesC$62,965 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.90 out of 5 stars 3.3 Analyst's Opinion Consensus RatingOrganigram has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageOrganigram has only been the subject of 3 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for OGI. Previous Next 0.0 Dividend Strength Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OGI. Previous Next 2.4 News and Social Media Coverage News SentimentOrganigram has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Organigram this week, compared to 1 article on an average week.Search Interest12 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$62,965.00 in company stock.Percentage Held by Insiders34.74% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 11.20% of the stock of Organigram is held by institutions. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioOrganigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Organigram Stock (TSE:OGI)Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.Read More OGI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OGI Stock News HeadlinesApril 21, 2024 | seekingalpha.comOrganigram Is My Favorite Cannabis Stock AgainApril 20, 2024 | seekingalpha.comOrganigram: Operating In A Structurally Challenged IndustryApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...April 18, 2024 | finance.yahoo.comOrganigram Holdings Inc. (OGI)April 8, 2024 | finance.yahoo.comOrganigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive YearMarch 29, 2024 | benzinga.comCanadian Cannabis Giant Sets Stage For Growth With $18.5M Public OfferingMarch 28, 2024 | cnn.comOrganiGram Holdings IncMarch 28, 2024 | msn.comOrganigram Holdings (TSE:OGI) Plunges amid Plans to Enter U.S. MarketApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...March 27, 2024 | theglobeandmail.comOrganiGram Holdings: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (OGI)March 27, 2024 | msn.comOrganigram slips after announcing C$25M stock offeringMarch 26, 2024 | msn.comOrganigram spikes after $2M investment in U.S.-based cannabinoid playerMarch 22, 2024 | finance.yahoo.comOrganigram Receives Health Canada’s Final Redetermination on JoltsMarch 16, 2024 | finance.yahoo.comOGI Apr 2024 1.500 putMarch 11, 2024 | theglobeandmail.comStrategic Investing with Eternity INC: A Guide to Building a Resilient PortfolioFebruary 28, 2024 | finance.yahoo.comOrganigram Applauds the Standing Committee on Finance’s Recommendation on Excise DutyFebruary 24, 2024 | fool.caThe Best Cannabis Stock to Buy Right NowFebruary 16, 2024 | finance.yahoo.comOGI Mar 2024 2.000 callFebruary 15, 2024 | seekingalpha.comOrganigram Holdings Inc. (OGI) Q1 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comOrganiGram Holdings Inc. (NASDAQ:OGI) Q1 2024 Earnings Call TranscriptFebruary 13, 2024 | markets.businessinsider.comBuy Rating Affirmed for OrganiGram Holdings Amid Strong Profit Margins and Strategic Market PositioningFebruary 10, 2024 | ca.finance.yahoo.comOGI Sep 2024 2.000 putFebruary 10, 2024 | ca.finance.yahoo.comOGI Sep 2024 5.000 callJanuary 31, 2024 | finance.yahoo.comOrganigram Completes First Shipment to Germany, Extending its International ReachJanuary 24, 2024 | finance.yahoo.comOrganigram Announces the First Tranche Closing from BAT InvestmentJanuary 22, 2024 | theglobeandmail.comOrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI)January 2, 2024 | seekingalpha.comWhy Organigram Is My Favorite Cannabis StockSee More Headlines Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/22/2024Next Earnings (Estimated)4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis Current SymbolTSE:OGI CUSIPN/A CIKN/A Webwww.organigram.ca Phone844-644-4726FaxN/AEmployees984Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.85 High Stock Price TargetC$5.25 Low Stock Price TargetC$2.70 Potential Upside/Downside+48.1%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($2.51) Trailing P/E RatioN/A Forward P/E Ratio28.21 P/E Growth0.42Net IncomeC$-229,480,000.00 Net Margins-153.80% Pretax MarginN/A Return on Equity-54.53% Return on Assets-5.56% Debt Debt-to-Equity Ratio1.75 Current Ratio6.95 Quick Ratio2.62 Sales & Book Value Annual SalesC$149.21 million Price / Sales1.64 Cash FlowC$0.67 per share Price / Cash Flow3.85 Book ValueC$3.18 per share Price / Book0.82Miscellaneous Outstanding Shares94,100,000Free FloatN/AMarket CapC$244.66 million OptionableNot Optionable Beta1.11 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Beena G. Goldenberg (Age 60)CEO & Director Comp: $485.33kMs. Helen Martin (Age 46)Chief Legal Officer & Corporate Secretary Comp: $307.95kMr. Timothy EmbergChief Commercial OfficerMr. Paolo De Luca C.A. (Age 51)C.F.A, Chief Strategy Officer Comp: $306.7kMr. Greg Guyatt C.A.CPA, Chief Financial OfficerMs. Nathalie BattenSenior Vice President of OperationsMr. Geoff RiggsChief Information OfficerMax SchwartzDirector of Investor RelationsMs. Megan Amber McCraeSenior Vice President of Marketing & CommunicationsMs. Katrina May McFaddenChief People OfficerMore ExecutivesKey CompetitorsICC LabsCVE:ICCLeaf MobileTSE:LEAFCanopy GrowthTSE:WEEDESSA PharmaCVE:EPISupreme CannabisTSE:FIREView All CompetitorsInsidersDonald Geoffrey MachumSold 23,000 sharesTotal: C$62,964.80 ($2.74/share) OGI Stock Analysis - Frequently Asked Questions Should I buy or sell Organigram stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OGI shares. View OGI analyst ratings or view top-rated stocks. What is Organigram's stock price target for 2024? 3 brokerages have issued 12 month price targets for Organigram's shares. Their OGI share price targets range from C$2.70 to C$5.25. On average, they expect the company's stock price to reach C$3.85 in the next twelve months. This suggests a possible upside of 48.1% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts. How have OGI shares performed in 2024? Organigram's stock was trading at C$1.72 at the beginning of the year. Since then, OGI shares have increased by 51.2% and is now trading at C$2.60. View the best growth stocks for 2024 here. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024. View our OGI earnings forecast. How were Organigram's earnings last quarter? Organigram Holdings Inc. (TSE:OGI) issued its quarterly earnings results on Tuesday, February, 13th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.06. The business earned $36.46 million during the quarter, compared to analysts' expectations of $38.13 million. Organigram had a negative trailing twelve-month return on equity of 54.53% and a negative net margin of 153.80%. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), Green Organic Dutchman (TGOD), Charlotte's Web (CWBHF) and CannTrust (CTST). How do I buy shares of Organigram? Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:OGI) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
